Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| VT Develops intelligent, logic-gated therapeutics for solid tumors | $61M | Series A | Biotech | China | Investors | |
Ranked by rounds participated in · From Jan 1, 2026
Metriport, Arintra, Multiplier
Transfyr, General Intuition, Castelion
Rillet, Castelion, Hadrian
SiFly Aviation, Apollo Atomics, Hopscotch Primary Care
Higgsfield, Lovable, Cambridge Aerospace
Explore published rounds while the next edition is being prepared.
Develops AI-enabled cardiac diagnostics platform for ECG interpretation
| Undisclosed |
| Seed |
| Healthtech |
| United Kingdom |
| Investors |
| TI Terra IndustriesCompany profile Builds autonomous defense systems and infrastructure for countries in the Global South Builds autonomous defense systems and infrastructure for countries in the Global South | $11.8M | Undisclosed | Defense tech | Nigeria | Investors |
| T Provides spa, bathhouse, leisure, and activity management software | $30M | Series A | Enterprise software | United Kingdom | Investors |
| N Develops implant for treating articular cartilage defects in the knee | $4.1M | Seed2Seed | Biotech | United States | Investors |
| AP Develops, constructs, owns, and operates renewable energy assets | $200M | StrategicUndisclosed | Climate tech | United States | Investors |
| V Provides intelligent software platforms for oncology care | $43M | Undisclosed | Healthtech | United States | Investors |
| ZI Zepo IntelligenceCompany profile Develops a workspace security platform combining human risk management with real-time threat dete... Develops a workspace security platform combining human risk management with real-time threat dete... | $15M | Seed | Cybersecurity | United States | Investors |
| MT Mirador TherapeuticsCompany profile Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases | $250M | Series B | Biotech | United States | Investors |
| A Develops AI-powered eye care solutions | CA$3.7M | Undisclosed | AI | Canada | Investors Undisclosed |